Humanigen Submits Application to FDA for Emergency Use Authorization for Lenzilumab in COVID-19

BURLINGAME, Calif.--(BUSINESS WIRE)--Humanigen announces submission of application to the FDA requesting Emergency Use Authorization for lenzilumab

Click to view original post